Association between fibrinogen and fibrinogen γ’ and atherosclerotic plaque morphology and composition in symptomatic carotid artery stenosis: Plaque-At-RISK study

Autor: van Dijk, A.C., Donkel, S.J., Zadi, T., Sonneveld, M.A.H., Schreuder, F.H.B.M., Chohan, M.F., Koudstaal, P.J., Leebeek, F.W.G., Saxena, R., Hendrikse, J., Kooi, M.E., van der Lugt, A., de Maat, M.P.M.

Publikováno v: In Thrombosis Research May 2019 177:130-135

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fibrinogen γ’ levels in patients with intracerebral hemorrhage

Autor: van den Herik, E.G., Cheung, E.Y.L., de Lau, L.M.L., den Hertog, H.M., Leebeek, F.W.G., Dippel, D.W.J., Koudstaal, P.J., de Maat, M.P.M.

Publikováno v: In Thrombosis Research June 2012 129(6):807-809

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED):an open-label, multicentre, randomised controlled trial

Autor: Steen, W. van der, Graaf, R.A.V. de, Chalos, V., Lingsma, H.F., Doormaal, P.J. van, Coutinho, J.M., Emmer, B.J., Ridder, I. de, Zwam, W. van, Worp, H.B. van der, Schaaf, I. van der, Gons, R.A.R., Yo, L.S.F., Boiten, J., Wijngaard, I. van den, Hofmeijer, J., Martens, J., Schonewille, W., Vos, J.A., Tuladhar, A.M., Laat, K.F. de, Hasselt, B. van, Remmers, M., Vos, D., Rozeman, A., Elgersma, O., Uyttenboogaart, M., Bokkers, R.P.H., Tuijl, J. van, Boukrab, I., Berg, R. van den, Beenen, L.F.M., Roosendaal, S.D., Postma, A.A., Krietemeijer, M., Lycklama, G., Meijer, F.J.A., Hammer, S., Hoorn, A. van der, Yoo, A.J., Gerrits, D., Truijman, M.T.B., Zinkstok, S., Koudstaal, P.J., Manschot, S., Kerkhoff, H., Nieboer, D., Berkhemer, O., Wolff, L., Sluijs, P.M. van der, Voorst, H. van, Tolhuisen, M., Roos, Y.B.W.E.M., Majoie, C.B.L.M., Staals, J., Oostenbrugge, R.J. van, Jenniskens, S.F.M., Dijk, L.C. van, Hertog, H.M. den, Es, A.C.G.M. van, Lugt, A. van der, Dippel, D.W.J., Roozenbeek, B., MR CLEAN-MED Investigators

Publikováno v: MR CLEAN-MED Investigators 2022, ' Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED) : an open-label, multicentre, randomised controlled trial ', The Lancet, vol. 399, no. 10329, pp. 1059-1069 . https://doi.org/10.1016/S0140-6736(22)00014-9
The Lancet, 399(10329), 1059-1069. ELSEVIER SCIENCE INC
The Lancet (London), 399, 1059-1069
The Lancet, 399(10329), 1059-1069. Elsevier Limited
The Lancet, 399(10329), 1059-1069. Elsevier Ltd.
The Lancet (London), 399, 10329, pp. 1059-1069
Lancet, 399(10329), 1059-1069. Elsevier Science

BACKGROUND: Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of anti-thrombotics for this indication are unknown. We therefore aimed to assess t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8953cfdde4fc4e0b25a24d129984fa64
https://research.vumc.nl/en/publications/155f1e87-ba12-4257-8269-1662795d2460